Skip to main content
Top
Published in: Familial Cancer 2/2020

Open Access 01-04-2020 | Endometrial Cancer | Original Article

Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study

Authors: Mari H. Kalamo, J. U. Mäenpää, T. T. Seppälä, J. P. Mecklin, H. Huhtala, K. Sorvettula, K. Pylvänäinen, S. Staff

Published in: Familial Cancer | Issue 2/2020

Login to get access

Abstract

To prevent endometrial carcinoma in Lynch syndrome (LS), regular gynecological surveillance visits and prophylactic surgery are recommended. Previous data have shown that prophylactic hysterectomy is an effective means of cancer prevention, while the advantages and disadvantages of surveillance are somewhat unclear. We aimed to evaluate female LS carriers’ attitudes towards regular gynecological surveillance and factors influencing their decision-making on prophylactic surgery that have not been well documented. Pain experienced during endometrial biopsies was also evaluated. Postal questionnaires were sent to LS carriers undergoing regular gynecological surveillance. Questionnaires were sent to 112 women with LS, of whom 76 responded (68%). Forty-two (55%) had undergone prophylactic hysterectomy by the time of the study. The majority of responders (64/76; 84.2%) considered surveillance appointments beneficial. Pain level during endometrial biopsy was not associated with the decision to undergo prophylactic surgery. The level of satisfaction the women had with the information and advice provided during surveillance was significantly associated with the history of prophylactic hysterectomy (satisfaction rate of 73.2% versus 31.8% of nonoperated women, p = 0.003). The women who had undergone prophylactic surgery were older than the nonoperated women both at mutation testing (median of 42.3 years versus 31.6 years, p < 0.001) and at the time of the study (median of 56.9 years versus 46.0 years, respectively, p < 0.001). Women with LS pathogenic variants have positive experiences with gynecological surveillance visits, and their perception of the quality of the information and advice obtained plays an important role in their decision-making concerning prophylactic surgery.
Literature
1.
go back to reference Aarnio M et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218CrossRef Aarnio M et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218CrossRef
2.
go back to reference Møller P et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut 67(7):1306–1316CrossRef Møller P et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut 67(7):1306–1316CrossRef
3.
go back to reference Lu KH, Daniels M (2013) Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention. Fam Cancer 12(2):273–277CrossRef Lu KH, Daniels M (2013) Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention. Fam Cancer 12(2):273–277CrossRef
4.
go back to reference Herzig DO et al (2017) Clinical practice guidelines for the surgical treatment of patients with lynch syndrome. Dis Colon Rectum 60(2):137–143CrossRef Herzig DO et al (2017) Clinical practice guidelines for the surgical treatment of patients with lynch syndrome. Dis Colon Rectum 60(2):137–143CrossRef
5.
go back to reference Møller P et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66(3):464–472CrossRef Møller P et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66(3):464–472CrossRef
6.
go back to reference Schmeler KM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRef Schmeler KM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRef
7.
go back to reference Nyström-Lahti M et al (1995) Founding mutations and alu-mediated recombination in hereditary colon cancer. Nat Med 1(11):1203–1206CrossRef Nyström-Lahti M et al (1995) Founding mutations and alu-mediated recombination in hereditary colon cancer. Nat Med 1(11):1203–1206CrossRef
8.
go back to reference Etchegary H, Dicks E, Watkins K, Alani S, Dawson L (2015) Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers. Hered Cancer Clin Pract 13(1):10CrossRef Etchegary H, Dicks E, Watkins K, Alani S, Dawson L (2015) Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers. Hered Cancer Clin Pract 13(1):10CrossRef
9.
go back to reference Etchegary H, Dicks E, Tamutis L, Dawson L (2018) Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers. Fam Cancer 17(1):53–61CrossRef Etchegary H, Dicks E, Tamutis L, Dawson L (2018) Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers. Fam Cancer 17(1):53–61CrossRef
10.
go back to reference Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M (2017) Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer 16(2):205–210CrossRef Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M (2017) Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer 16(2):205–210CrossRef
11.
go back to reference Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin J-P (2009) Ten years after mutation testing for lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27(28):4793–4797CrossRef Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin J-P (2009) Ten years after mutation testing for lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27(28):4793–4797CrossRef
12.
go back to reference Mecklin JP (1987) Frequency of hereditary colorectal carcinoma. Gastroenterology 93(5):1021–1025CrossRef Mecklin JP (1987) Frequency of hereditary colorectal carcinoma. Gastroenterology 93(5):1021–1025CrossRef
13.
go back to reference Gylling A et al (2009) Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer 124(10):2333–2340CrossRef Gylling A et al (2009) Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer 124(10):2333–2340CrossRef
14.
go back to reference Staff S, Aaltonen M, Huhtala H, Pylvänäinen K, Mecklin J-P, Mäenpää J (2016) Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study. Br J Cancer 115(3):375–381CrossRef Staff S, Aaltonen M, Huhtala H, Pylvänäinen K, Mecklin J-P, Mäenpää J (2016) Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study. Br J Cancer 115(3):375–381CrossRef
15.
go back to reference Aaltonen MH, Staff S, Mecklin J-P, Pylvänäinen K, Mäenpää JU (2017) Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: a retrospective case-case study. Mol Clin Oncol 6(5):758–764CrossRef Aaltonen MH, Staff S, Mecklin J-P, Pylvänäinen K, Mäenpää JU (2017) Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: a retrospective case-case study. Mol Clin Oncol 6(5):758–764CrossRef
16.
go back to reference Auranen A, Joutsiniemi T (May 2011) A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand 90(5):437–444CrossRef Auranen A, Joutsiniemi T (May 2011) A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand 90(5):437–444CrossRef
Metadata
Title
Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study
Authors
Mari H. Kalamo
J. U. Mäenpää
T. T. Seppälä
J. P. Mecklin
H. Huhtala
K. Sorvettula
K. Pylvänäinen
S. Staff
Publication date
01-04-2020
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2020
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00158-5

Other articles of this Issue 2/2020

Familial Cancer 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine